SCOPUS 정보 검색 플랫폼

Bulletin of Experimental Biology and Medicine

Volumn 149, Issue 1, 2010, Pages 33-36

Donepezil eliminates suppressive effects of β-amyloid peptide (1-42) on long-term potentiation in the hippocampus

(3) Kapai, N A a Solntseva, E I a Skrebitskii, V G a

a RESEARCH CENTER OF NEUROLOGY (Russian Federation)

Author keywords

amyloid peptide; donepezil; hippocampus; long term potentiation

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; DONEPEZIL;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL POPULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HIPPOCAMPUS; LONG TERM POTENTIATION; MALE; NEUROMODULATION; NONHUMAN; POST TETANIC POTENTIATION; PYRAMIDAL NERVE CELL; RAT;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; HIPPOCAMPUS; INDANS; LONG-TERM POTENTIATION; MALE; NEUROPROTECTIVE AGENTS; PEPTIDE FRAGMENTS; PIPERIDINES; RATS; RATS, WISTAR; STATISTICS, NONPARAMETRIC;

RATTUS;

EID: 77954427168 PISSN: 00074888 EISSN: None Source Type: Journal
DOI: 10.1007/s10517-010-0868-5 Document Type: Article

Times cited : (5)

References (15)

1
- 33845411954
- AMPAR Removal Underlies Aβ-Induced Synaptic Depression and Dendritic Spine Loss
- DOI 10.1016/j.neuron.2006.10.035, PII S0896627306008725
- H Hsieh J Boehm C Sato, et al. 2006 Neuron 52 5 831 843 10.1016/j.neuron.2006.10.035 1:CAS:528:DC%2BD28XhtlCnsr7M 17145504 (Pubitemid 44828454)
- (2006) Neuron , vol.52 , Issue.5 , pp. 831-843
- Hsieh, H.¹ Boehm, J.² Sato, C.³ Iwatsubo, T.⁴ Tomita, T.⁵ Sisodia, S.⁶ Malinow, R.⁷

2
- 0033593489
- TAK-147, an acetylcholinesterase inhibitor, increases choline acetyltransferase activity in cultured rat septal cholinergic neurons
- DOI 10.1016/S0304-3940(98)00943-4, PII S0304394098009033
- K Kato H Hayako Y Ishihara, et al. 1999 Neurosci. Lett. 260 1 5 8 10.1016/S0304-3940(98)00943-4 1:CAS:528:DyaK1MXhslejsg%3D%3D 10027686 (Pubitemid 29066888)
- (1999) Neuroscience Letters , vol.260 , Issue.1 , pp. 5-8
- Kato, K.¹ Hayako, H.² Ishihara, Y.³ Marui, S.⁴ Iwane, M.⁵ Miyamoto, M.⁶

3
- 0035866076
- 1:CAS:528:DC%2BD3MXhtFersbo%3D 11160403
- JH Kim R Anwyl YH Suh, et al. 2001 J. Neurosci. 21 4 1327 1333 1:CAS:528:DC%2BD3MXhtFersbo%3D 11160403
- (2001) J. Neurosci. , vol.21 , Issue.4 , pp. 1327-1333
- Kim, J.H.¹ Anwyl, R.² Suh, Y.H.³

4
- 20444381285
- Protective effect of donepezil against Aβ(1-40) neurotoxicity in rat septal neurons
- DOI 10.1016/j.brainres.2005.04.014, PII S0006899305005160
- M Kimura S Akasofu H Ogura K Sawada 2005 Brain Res. 1047 1 72 84 10.1016/j.brainres.2005.04.014 1:CAS:528:DC%2BD2MXltFSrtrc%3D 15893738 (Pubitemid 40805032)
- (2005) Brain Research , vol.1047 , Issue.1 , pp. 72-84
- Kimura, M.¹ Akasofu, S.² Ogura, H.³ Sawada, K.⁴

5
- 28544434902
- Up-regulation of nicotinic acetylcholine receptors by central-type acetylcholinesterase inhibitors in rat cortical neurons
- DOI 10.1016/j.ejphar.2005.10.028, PII S0014299905010940
- T Kume M Sugimoto Y Takada, et al. 2005 Eur. J. Pharmacol. 527 1-3 77 85 10.1016/j.ejphar.2005.10.028 1:CAS:528:DC%2BD2MXht1Olur3E 16313899 (Pubitemid 41745154)
- (2005) European Journal of Pharmacology , vol.527 , Issue.1-3 , pp. 77-85
- Kume, T.¹ Sugimoto, M.² Takada, Y.³ Yamaguchi, T.⁴ Yonezawa, A.⁵ Katsuki, H.⁶ Sugimoto, H.⁷ Akaike, A.⁸

6
- 33845651380
- 1 receptor
- DOI 10.1038/sj.bjp.0706927, PII 0706927
- J Meunier J Ieni T Maurice 2006 Br. J. Pharmacol. 149 8 998 1012 10.1038/sj.bjp.0706927 1:CAS:528:DC%2BD28Xht12gsLvN 17057756 (Pubitemid 44950803)
- (2006) British Journal of Pharmacology , vol.149 , Issue.8 , pp. 998-1012
- Meunier, J.¹ Ieni, J.² Maurice, T.³

7
- 25644432066
- Modulation of N-methyl-D-aspartate receptors by donepezil in rat cortical neurons
- DOI 10.1124/jpet.105.087908
- S Moriguchi X Zhao W Marszalec, et al. 2005 J. Pharmacol. Exp. Ther. 315 1 125 135 10.1124/jpet.105.087908 1:CAS:528:DC%2BD2MXhtVOks7%2FM 15951396 (Pubitemid 41380505)
- (2005) Journal of Pharmacology and Experimental Therapeutics , vol.315 , Issue.1 , pp. 125-135
- Moriguchi, S.¹ Zhao, X.² Marszalec, W.³ Yeh, J.Z.⁴ Narahashi, T.⁵

8
- 23144463734
- Alzheimer's disease-associated neurotoxic mechanisms and neuroprotective strategies
- DOI 10.2174/1568007054546117
- C Pereira P Agostinho PI Moreira, et al. 2005 Curr. Drug Targets CNS Neurol. Disord. 4 4 383 403 10.2174/1568007054546117 1:CAS:528: DC%2BD2MXmvVyktL8%3D 16101556 (Pubitemid 41086757)
- (2005) Current Drug Targets: CNS and Neurological Disorders , vol.4 , Issue.4 , pp. 383-403
- Pereira, C.¹ Agostinho, P.² Moreira, P.I.³ Cardoso, S.M.⁴ Oliveira, C.R.⁵

9
- 0032507788
- Donepezil improves cognition and global function in Alzheimer disease: A 15-week, double-blind, placebo-controlled study
- DOI 10.1001/archinte.158.9.1021
- SL Rogers RS Doody RS Mohs LT Friedhoff 1998 Arch. Intern. Med. 158 9 1021 1031 10.1001/archinte.158.9.1021 1:CAS:528:DyaK1cXjt1yhsL0%3D 9588436 (Pubitemid 28213580)
- (1998) Archives of Internal Medicine , vol.158 , Issue.9 , pp. 1021-1031
- Rogers, S.L.¹ Doody, R.S.² Mohs, R.C.³ Friedhoff, L.T.⁴

10
- 0037174618
- Alzheimer's disease is a synaptic failure
- DOI 10.1126/science.1074069
- DJ Selkoe 2002 Science 298 789 791 10.1126/science.1074069 1:CAS:528:DC%2BD38XotFSnur0%3D 12399581 (Pubitemid 35231524)
- (2002) Science , vol.298 , Issue.5594 , pp. 789-791
- Selkoe, D.J.¹

11
- 33846648976
- Donepezil is a strong antagonist of voltage-gated calcium and potassium channels in molluscan neurons
- DOI 10.1016/j.cbpc.2006.10.001, PII S1532045606002201
- EI Solntseva JV Bukanova E Marchenko VG Skrebitsky 2007 Comp. Biochem. Physiol. C. Toxicol. Pharmacol. 144 4 319 326 10.1016/j.cbpc.2006.10.001 17126610 (Pubitemid 46177765)
- (2007) Comparative Biochemistry and Physiology - C Toxicology and Pharmacology , vol.144 , Issue.4 , pp. 319-326
- Solntseva, E.I.¹ Bukanova, J.V.² Marchenko, E.³ Skrebitsky, V.G.⁴

12
- 2942542795
- Pharmacotherapeutic approaches to the treatment of Alzheimer's disease
- DOI 10.1016/S0149-2918(04)90064-1
- JB Standridge 2004 Clin. Ther. 26 5 615 630 10.1016/S0149-2918(04)90064-1 1:CAS:528:DC%2BD2cXlsFCis7g%3D 15220008 (Pubitemid 38736954)
- (2004) Clinical Therapeutics , vol.26 , Issue.5 , pp. 615-631
- Standridge, J.B.¹

13
- 0025987048
- 10.1002/ana.410300410 1:STN:280:DyaK387mtFOntw%3D%3D 1789684
- RD Terry E Masliah DP Salmon 1991 Ann. Neurol. 30 4 572 580 10.1002/ana.410300410 1:STN:280:DyaK387mtFOntw%3D%3D 1789684
- (1991) Ann. Neurol. , vol.30 , Issue.4 , pp. 572-580
- Terry, R.D.¹ Masliah, E.² Salmon, D.P.³

14
- 1842610852
- Block of Long-Term Potentiation by Naturally Secreted and Synthetic Amyloid β-Peptide in Hippocampal Slices Is Mediated via Activation of the Kinases c-Jun N-Terminal Kinase, Cyclin-Dependent Kinase 5, and p38 Mitogen-Activated Protein Kinase as well as Metabotropic Glutamate Receptor Type 5
- DOI 10.1523/JNEUROSCI.1633-03.2004
- Q Wang DM Walsh MJ Rowan, et al. 2004 J. Neurosci. 24 13 3370 3378 10.1523/JNEUROSCI.1633-03.2004 1:CAS:528:DC%2BD2cXjt1yhsL0%3D 15056716 (Pubitemid 38451902)
- (2004) Journal of Neuroscience , vol.24 , Issue.13 , pp. 3370-3378
- Wang, Q.¹ Walsh, D.M.² Rowan, M.J.³ Selkoe, D.J.⁴ Anwyl, R.⁵

15
- 0032754141
- Suppressive action produced by β-amyloid peptide fragment 31-35 on long-term potentiation in rat hippocampus is N-methyl-D-aspartate receptor-independent: It's offset by (-)huperzine A
- DOI 10.1016/S0304-3940(99)00795-8, PII S0304394099007958
- L Ye JT Qiao 1999 Neurosci. Lett. 275 3 187 190 10.1016/S0304-3940(99) 00795-8 1:CAS:528:DyaK1MXnvFWqtL0%3D 10580706 (Pubitemid 29507538)
- (1999) Neuroscience Letters , vol.275 , Issue.3 , pp. 187-190
- Ye, L.¹ Qiao, J.-T.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.